Brief: InMed Pharmaceuticals Receives Nasdaq Delisting Notice, Confirms It Has Filed Appeal & Obtained Panel Hearing Date
20/09/2024 21:28
Sept 20 (Reuters) - InMed Pharmaceuticals Inc INM.O :
* INMED PHARMACEUTICALS: RECEIVES NASDAQ DELISTING NOTICE,
CONFIRMS IT HAS FILED APPEAL & OBTAINED PANEL HEARING DATE
Source text for Eikon: ID:n0001213900-24-080662
Further company coverage: INM.O
(Reuters.Briefs@thomsonreuters.com)